Make your money go further for just 25p per day

PREMIUM
AIM IHT

Bonkers Bargain: encouraging trading update

AI imagery

This small medical imaging advanced analytics company delivering insights in neuroscience has loads of potential and continues to look cracking value at current levels. Our in-depth commentary here highlights its appeal in a sector which is predicted to grow significantly. The order book offers plenty of visibility and this fascinating business is certainly worth a close look. An encouraging trading update bodes well. It's certainly not our usual type of Bonkers Bargain, but exciting nonetheless!  


IXICO (LON:IXI) is an Artificial Intelligence (‘AI’) data analytics company delivering intelligent insights in neuroscience. Its purpose is to advance medicine and human health in neuroscience by converting raw clinical trial data into clinically meaningful information.


Through the deployment of novel Artificial Intelligence (‘AI’) algorithms, IXICO analyses and interprets brain scans and wearable biosensor data to enable better trial design, patient selection and ultimately better clinical outcomes across all phases of clinical evaluation.

The Group is a…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on IXICO

Bonkers Bargain: encouraging trading update

16/04/2025 · Company Insights

This small medical imaging advanced analytics company delivering insights in neuroscience has loads of potential and…


Cash flow delights | Modestly valued | Growth expectations

27/02/2025 · Company Insights

News here includes our coverage of results from a large veterinary group, whose shares remain under…


More Portfolio

Income Boosters portfolio: 7.8% yield and takeover interest

07/04/2025

When knocking the lights out isn’t enough

28/02/2025 · Apple · Booking Holdings · Intuit · Nvidia · Relx · Starbucks · Unilever

Sign-up to our free email updates

SIGN UP